Expertise in
16
conditions

Erica T. Van Den Akker

Erasmus MC
Rotterdam, ZH, NL 
Expertise in
16
conditions
Erasmus MC
Rotterdam, ZH, NL 

Overview

Erica Van Den Akker practices practicing medicine in Rotterdam, Netherlands.

Ms. Van Den Akker is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Obesity, Obesity in Children, Congenital Adrenal Hyperplasia (CAH), Intersex, and Hormone Replacement Therapy (HRT).

She is actively involved in clinical research, co-authoring 157 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Erasmus MC
Rotterdam, ZH, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Enrollment Status: Completed
Publish Date: August 18, 2023
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2
An Open Label, 1-Year Trial, Including a Double-Blind Placebo-Controlled Withdrawal Period, of Setmelanotide (RM-493), a Melanocortin 4 Receptor (MC4R) Agonist, in Leptin Receptor (LEPR) Deficiency Obesity Due to Bi-Allelic Loss-of-Function LEPR Genetic Mutation
An Open Label, 1-Year Trial, Including a Double-Blind Placebo-Controlled Withdrawal Period, of Setmelanotide (RM-493), a Melanocortin 4 Receptor (MC4R) Agonist, in Leptin Receptor (LEPR) Deficiency Obesity Due to Bi-Allelic Loss-of-Function LEPR Genetic Mutation
Enrollment Status: Completed
Publish Date: May 23, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

157 Total Publications

CheckCausesObesity.com: a screening and monitoring tool for obesity.
CheckCausesObesity.com: a screening and monitoring tool for obesity.
Journal: Nature reviews. Endocrinology
Published: September 02, 2026

Frequently Asked Questions about Erica T. Van Den Akker

Is Erica T. Van Den Akker a top-rated expert for Obesity?

MediFind is an objective health platform that identifies experts based on real-world data. Erica T. Van Den Akker is classified as an Elite expert for Obesity, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Erica T. Van Den Akker participate in research or clinical trials?

Yes. Erica T. Van Den Akker has published 157 articles and abstracts on conditions like Obesity. You can view a list of Erica T. Van Den Akker's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Van Den Akker's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 30 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile